Jan C. Oosterwijk

9.8k total citations · 1 hit paper
124 papers, 4.3k citations indexed

About

Jan C. Oosterwijk is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Cancer Research. According to data from OpenAlex, Jan C. Oosterwijk has authored 124 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Genetics, 26 papers in Pediatrics, Perinatology and Child Health and 25 papers in Cancer Research. Recurrent topics in Jan C. Oosterwijk's work include BRCA gene mutations in cancer (73 papers), Prenatal Screening and Diagnostics (20 papers) and Cancer Genomics and Diagnostics (18 papers). Jan C. Oosterwijk is often cited by papers focused on BRCA gene mutations in cancer (73 papers), Prenatal Screening and Diagnostics (20 papers) and Cancer Genomics and Diagnostics (18 papers). Jan C. Oosterwijk collaborates with scholars based in Netherlands, United States and United Kingdom. Jan C. Oosterwijk's co-authors include Emiel J. Rutgers, Geertruida H. de Bock, Harry J. de Koning, Madeleine M.A. Tilanus‐Linthorst, Rob A.�E.�M. Tollenaar, C. Boetes, Mieke Kriege, Cecile T.M. Brekelmans, Marian J.E. Mourits and Jan G.M. Klijn and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jan C. Oosterwijk

120 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition

2004 1.2k citations Mieke Kriege, Cecile T.M. Brekelmans et al. profile →

Peers

Jan C. Oosterwijk

GENET

ONCOL

PFM

RNMI

Cecile T.M. Brekelmans Netherlands

Madeleine M.A. Tilanus‐Linthorst Netherlands

James Mackay United Kingdom

Anja Wagner Netherlands

Wendy Kohlmann United States

Michael P. Lux Germany

Lee-may Chen United States

G. Bruce Mann Australia

Murali Chintagumpala United States

Siegal Sadetzki Israel

Cecile T.M. Brekelmans Netherlands

Jan C. Oosterwijk

2.6k ×1.3

GENET

1.3k ×1.4

ONCOL

1.6k ×1.8

1.2k ×1.4

PFM

790 ×1.0

RNMI

Citations per year, relative to Jan C. Oosterwijk Jan C. Oosterwijk (= 1×) peers Cecile T.M. Brekelmans

Countries citing papers authored by Jan C. Oosterwijk

Since Specialization

Citations

This map shows the geographic impact of Jan C. Oosterwijk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan C. Oosterwijk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan C. Oosterwijk more than expected).

Fields of papers citing papers by Jan C. Oosterwijk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan C. Oosterwijk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan C. Oosterwijk. The network helps show where Jan C. Oosterwijk may publish in the future.

Co-authorship network of co-authors of Jan C. Oosterwijk

This figure shows the co-authorship network connecting the top 25 collaborators of Jan C. Oosterwijk. A scholar is included among the top collaborators of Jan C. Oosterwijk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan C. Oosterwijk. Jan C. Oosterwijk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuijk, Sander M. J. van, Cora M. Aalfs, Christi J. van Asperen, et al.. (2020). Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making. Journal of Community Genetics. 12(1). 101–110. 9 indexed citations

Bliek, Jet, Carel J.M. van Noesel, Laura J. C. M. van Zutven, et al.. (2019). Multiple tumors due to mosaic genome‐wide paternal uniparental disomy. Pediatric Blood & Cancer. 66(6). e27715–e27715. 10 indexed citations

Hout, Annemieke van der, Jan C. Oosterwijk, Janet R. Vos, et al.. (2018). The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?. European Journal of Human Genetics. 26(6). 848–857. 6 indexed citations

Moghadasi, Setareh, Luc Janssen, Mar Rodríguez‐Girondo, et al.. (2017). Performance of BRCA1/2 mutation prediction models in male breast cancer patients. Clinical Genetics. 93(1). 52–59. 3 indexed citations

Maistro, Simone, Maria Del Pilar Estevez-Diz, Marian J.E. Mourits, et al.. (2017). Predictability of BRCA1/2 mutation status in patients with ovarian cancer: How to select women for genetic testing in middle-income countries. Maturitas. 105. 113–118. 3 indexed citations

Vos, Janet R., Jan C. Oosterwijk, Cora M. Aalfs, et al.. (2016). Bias Explains Most of the Parent-of-Origin Effect on Breast Cancer Risk in BRCA1/2 Mutation Carriers. Cancer Epidemiology Biomarkers & Prevention. 25(8). 1251–1258. 5 indexed citations

Vos, Janet R., et al.. (2015). Inverse birth cohort effects in ovarian cancer: Increasing risk in BRCA1 / 2 mutation carriers and decreasing risk in the general population. Gynecologic Oncology. 140(2). 289–294. 1 indexed citations

Hes, Frederik J., et al.. (2015). [CHEK2-mutation in Dutch breast cancer families: expanding genetic testing for breast cancer].. PubMed. 159. A8910–A8910. 7 indexed citations

Adank, Muriel A., Frederik J. Hes, Wendy A.G. van Zelst–Stams, et al.. (2015). CHEK2-mutatie in Nederlandse borstkankerfamilies: uitbreiding van de genetische diagnostiek op borstkanker.. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 159(45). 1 indexed citations

10.

Brohet, Richard M., Frans B.L. Hogervorst, Hanne Meijers‐Heijboer, et al.. (2013). Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. Journal of Medical Genetics. 51(2). 98–107. 62 indexed citations

11.

Saadatmand, Sepideh, Emiel J. Rutgers, Linetta B. Koppert, et al.. (2012). Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial. BMC Cancer. 12(1). 440–440. 15 indexed citations

12.

Kolk, Dorina M. van der, Geertruida H. de Bock, Beike Leegte, et al.. (2010). Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Research and Treatment. 124(3). 643–651. 136 indexed citations

13.

Greuter, Marcel J. W., Marijke C. Jansen‐van der Weide, Cathrien Jacobi, et al.. (2009). The validation of a simulation model incorporating radiation risk for mammography breast cancer screening in women with a hereditary-increased breast cancer risk. European Journal of Cancer. 46(3). 495–504. 16 indexed citations

14.

Mourits, Marian J.E., Henriëtte J.G. Arts, J. de Vries, et al.. (2008). Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?. International Journal of Cancer. 124(4). 919–923. 97 indexed citations

15.

Kriege, Mieke, Cecile T.M. Brekelmans, C. Boetes, et al.. (2005). Efficacy of Magnetic Resonance Imaging and Mammography for Breast Cancer Screening in Women With a Familial or Genetic Predisposition. Obstetrical & Gynecological Survey. 60(2). 107–109. 8 indexed citations

16.

Oosterwijk, Jan C. & Margreet G.E.M. Ausems. (2005). Trends binnen de klinische genetica. University of Groningen research database (University of Groningen / Centre for Information Technology). 60. 1880–1883. 1 indexed citations

17.

Tilanus‐Linthorst, Madeleine M.A., Mieke Kriege, C. Boetes, et al.. (2005). Hereditary breast cancer growth rates and its impact on screening policy. European Journal of Cancer. 41(11). 1610–1617. 58 indexed citations

18.

Stalmeier, Peep F. M., Mariëlle S. van Roosmalen, Lia C.G. Verhoef, et al.. (2004). The decision evaluation scales. Patient Education and Counseling. 57(3). 286–293. 47 indexed citations

19.

Kriege, Mieke, Cecile T.M. Brekelmans, C. Boetes, et al.. (2003). MRI screening for breast cancer in women with high familial and genetic risk: First results of the Dutch MRI screening study (MRISC).. Journal of Clinical Oncology. 21(23). 12 indexed citations

20.

Boer, Anthonius de, et al.. (1995). Determination of a maximum number of artificial inseminations by donor children per sperm donor. Fertility and Sterility. 63(2). 419–421. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact